We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24B
AUM Growth
+$1.05B
Cap. Flow
-$221M
Cap. Flow %
-0.92%
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$114M
2
AET
Aetna Inc
AET
+$96.3M
3
TRV icon
Travelers Companies
TRV
+$94.5M
4
CHK
Chesapeake Energy Corporation
CHK
+$89M
5
AEE icon
Ameren
AEE
+$69.4M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$247M
2
VZ icon
Verizon
VZ
+$186M
3
MDT icon
Medtronic
MDT
+$150M
4
LO
LORILLARD INC COM STK
LO
+$126M
5
JCI icon
Johnson Controls International
JCI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 15.44%
2 Technology 14.68%
3 Financials 12.75%
4 Industrials 11.1%
5 Energy 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEG
826
DELISTED
INTEGRYS ENERGY GROUP INC COM (USA)
TEG
$1.44M 0.01%
20,228
+17,928
+779% +$1.08M
SBRA icon
827
Sabra Healthcare REIT
SBRA
$5.13B
$1.44M 0.01%
50,000
+16,000
+47% +$465K
CNX icon
828
CNX Resources
CNX
$4.99B
$1.43M 0.01%
37,198
-704
-2% -$25.8K
SWX icon
829
Southwest Gas
SWX
$6.28B
$1.42M 0.01%
26,850
+11,350
+73% +$602K
AG icon
830
First Majestic Silver
AG
$9.03B
$1.42M 0.01%
130,758
-64,284
-33% -$609K
ACOR
831
DELISTED
Acorda Therapeutics
ACOR
$1.4M 0.01%
345
-14
-4% -$57.1K
POM
832
DELISTED
PEPCO HOLDINGS, INC.
POM
$1.38M 0.01%
50,192
+22
+0% +$561
BYD icon
833
Boyd Gaming
BYD
$5.49B
$1.36M 0.01%
112,100
+2,800
+3% +$32.4K
CMA
834
DELISTED
Comerica
CMA
$1.36M 0.01%
27,100
-3,600
-12% -$176K
RL icon
835
Ralph Lauren
RL
$20.2B
$1.36M 0.01%
8,437
+1,756
+26% +$271K
BEE
836
DELISTED
STRATEGIC HOTELS & RESORTS, INC
BEE
$1.34M 0.01%
+114,900
New +$1.24M
VRE
837
DELISTED
Veris Residential
VRE
$1.34M 0.01%
62,500
+27,100
+77% +$573K
QLGC
838
DELISTED
QLOGIC CORP
QLGC
$1.33M 0.01%
132,200
– –
AIMC
839
DELISTED
Altra Industrial Motion Corp
AIMC
$1.33M 0.01%
36,500
-100
-0.3% -$3.51K
IOSP icon
840
Innospec
IOSP
$2.29B
$1.31M 0.01%
30,400
– –
UGI icon
841
UGI
UGI
$8.19B
$1.31M 0.01%
38,850
+32,250
+489% +$1.02M
AAWW
842
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$1.3M 0.01%
35,300
+17,000
+93% +$617K
SYKE
843
DELISTED
SYKES Enterprises Inc
SYKE
$1.29M 0.01%
59,400
-12,000
-17% -$243K
SIR
844
DELISTED
SELECT INCOME REIT
SIR
$1.29M 0.01%
98,962
+27,072
+38% +$353K
NWL icon
845
Newell Brands
NWL
$2.42B
$1.29M 0.01%
41,500
-171,550
-81% -$5.13M
SWBI icon
846
Smith & Wesson
SWBI
$586M
$1.28M 0.01%
114,358
– –
CRL icon
847
Charles River Laboratories
CRL
$13.1B
$1.27M 0.01%
23,700
– –
ILF icon
848
iShares Latin America 40 ETF
ILF
$3.87B
$1.26M 0.01%
33,047
– –
AKR icon
849
Acadia Realty Trust
AKR
$2.67B
$1.26M 0.01%
44,900
+15,900
+55% +$435K
NWLIA
850
DELISTED
NATL WESTN LIFE INS CO CL A
NWLIA
$1.25M 0.01%
5,000
+100
+2% +$24.9K
32 33
34
35 36

Similar funds

VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $92M AUM 25.18% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $91.7M AUM
CCAM
Crystal Cove Asset Management Newport Beach, California $91.7M AUM
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $91.6M AUM 9.52% 1-Year Est. Return
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
DCA
DB&C Advisors Holland, Michigan $92.4M AUM

Axa's Q2 2014 Portfolio in Review

As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
  • Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
  • Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
  • Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
  • Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
  • Axa opened 103 new positions and closed 115 in Q2 2014.
  • Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.

Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.